Katherine R. Tuttle

Medicine · Health Sciences

91h-index41.4kcitations665works16.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(233), Chronic Kidney Disease and Diabetes(188), Diabetes Management and Research(92), Renal Diseases and Glomerulopathies(75), Dialysis and Renal Disease Management(71)

Publications632 total

GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
Nature Reviews Nephrology·2026· 1 cited
Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine Project
Kidney Medicine·2025Open Access
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
JAMA Cardiology·2025· 2 cited
Front Cover
Diabetes Obesity and Metabolism·2025Open Access
A Systematic Literature Review of Coordinated Care in Cardiovascular-Kidney-Metabolic Conditions
Mayo Clinic Proceedings Innovations Quality & Outcomes·2025Open Access
Prerenalism—A Gap That Costs Lives, Hearts, and Kidneys
JAMA Cardiology·2025
Urine Extracellular Vesicle miRNA Changes Induced by Vicadrostat with/Without Empagliflozin in Patients with Chronic Kidney Disease
International Journal of Molecular Sciences·2025Open Access
REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide
Kidney International·2025· 2 citedOpen Access
From progression to remission: a new paradigm for success in chronic kidney disease
Kidney International·2025Open Access
Real-World Data
Kidney360·2025Open Access
Response to the letter to the editor entitled “Semaglutide and kidney function: direct kidney protection or an artifact?”
Kidney International·2025
Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction
JACC Heart Failure·2025· 1 citedOpen Access
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International·2025· 1 citedOpen Access
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review
Diabetes Obesity and Metabolism·2025
Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL Trial
Journal of the American Society of Nephrology·2025· 2 cited
Effect of Semaglutide on Kidney Outcomes: Pooled Analysis of the SELECT, FLOW, and SOUL Trials
Journal of the American Society of Nephrology·2025
Improving Kidney Failure Risk Predictions for Clinical Trials Across CKD Stages 1-4
Journal of the American Society of Nephrology·2025
#3201 Effects of vicadrostat with and without empagliflozin in people with chronic kidney disease by baseline BMI
Nephrology Dialysis Transplantation·2025Open Access
Waist Circumference and Kidney Outcomes in a Nationally Representative Patient Cohort
Journal of the American Society of Nephrology·2025
Progression of Cardio-Kidney-Metabolic Syndrome in Adolescents with Type 2 Diabetes
Journal of the American Society of Nephrology·2025
page 1 of 32Next →

Frequent Co-authors

Ian H. de Boer(13), Peter Rossing(10), George L. Bakris(9), Matthias Kretzler(8), Hiddo J.L. Heerspink(7), John R. Sedor(7), Josef Coresh(6), Joshua J. Neumiller(6), Kamlesh Khunti(6), Tami Sadusky(6), Sylvia E. Rosas(6), Laura Barisoni(6), Janani Rangaswami(5), Irl B. Hirsch(5), Sankar D. Navaneethan(5), Wasiu A. Olowu(5), Marcello Tonelli(5), Richard J. Johnson(4), Chiadi E. Ndumele(4), Sheryl L. Chow(4)